Gene dosage and selective expression modify phenotype in a Drosophila model of human mitochondrial disease
Janne M. Toivonen(Universidad de Zaragoza), Howard T. Jacobs(Tampere University of Applied Sciences), Shweta Manjiry(Tampere University Hospital), Serge Alziari(Centre National de la Recherche Scientifique), Sylvie Touraille(Centre National de la Recherche Scientifique), Kevin M.C. O’Dell(University of Glasgow)
Cited by 21
Related Papers
Mechanisms of Life Span Extension by Rapamycin in the Fruit Fly Drosophila melanogaster
|Cell Metabolism|2010|1.1k
In Vivo Functional Analysis of the Human Mitochondrial DNA Polymerase POLG Expressed in Cultured Human Cells
|Journal of Biological Chemistry|2000|193
Expression of the Ciona intestinalis Alternative Oxidase (AOX) in Drosophila Complements Defects in Mitochondrial Oxidative Phosphorylation
|Cell Metabolism|2009|188
MicroRNA-206: A Potential Circulating Biomarker Candidate for Amyotrophic Lateral Sclerosis
|PLoS ONE|2014|186
Endocrine regulation of aging and reproduction in Drosophila
|Molecular and Cellular Endocrinology|2008|168